Delivery Order SPE2DB22D2206-SPE2DB24FGV97
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of the drug BARHEMSYS 5 MG/2 ML VIAL 2ML. The contract has a firm fixed price of $1,621.32 and a completion date of July 25, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of BARHEMSYS 5 MG/2 ML VIAL 2ML, a pharmaceutical product. The contract has a firm fixed price of $1,368.43 and an ultimate completion date of August 29, 2024. It is not a set-aside contract. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this award, which is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of BARHEMSYS 10 MG/4 ML VIAL 4ML, a pharmaceutical product, with a ceiling value of $10,189.98 and an ultimate completion date of June 27, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to various...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of BARHEMSYS 10 mg/4 ml vials with a ceiling value of $1,285.79. This competitively awarded, firm fixed-price delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract carries an ultimate completion date...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Barhemsys 10 mg/4 ml vials totaling $21,256.63 under a firm fixed price contract. The award was made on December 11, 2025, with an ultimate completion date of December 12, 2025, and represents a non-competitive set-aside delivery order. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is for the delivery of the drug Barhemsys, a nausea and vomiting medication, with a ceiling value of $3,412.50. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00 through December 2025. This single-award IDC serves...
- The Defense Logistics Agency issued a $2,329.16 delivery order to Amerisourcebergen Drug Corp on April 6, 2026, for Barhemsys 5 mg/2 ml vial pharmaceutical supply. This is a call against the DLA Troop Support Medical Indefinite Delivery Contract (IDC), valued at up to $999,999,999.00 through December 2026, which provides comprehensive global pharmaceutical support to military healthcare programs. Place of performance is Conshohocken, PA. The order carries firm fixed-price pricing with an...
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on March 31, 2026, for barhemsys 10 mg/4 ml vial (4 ml) with a firm fixed price ceiling of $1,191.16. Place of performance is Conshohocken, PA. The order has an ultimate completion date of April 1, 2026. No set-aside was used. The order was issued under the parent Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at up to $999,999,999.00...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a Ceiling Value of $13,692.36 and a performance period running through January 28, 2025. It is a Firm Fixed Price contract for the delivery of a variety of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes,...
- The Defense Logistics Agency issued a $19,114.71 delivery order to Amerisourcebergen Drug Corp on January 26, 2026, for barhemsys 10 mg/4 ml vial pharmaceutical supply. The order is issued under the DLA Troop Support Medical indefinite delivery contract SPE2DX, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. Place of performance is Conshohocken, Pennsylvania. The order has a firm fixed price structure and an ultimate completion date of...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FGV97Delivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division for the procurement of BARHEMSYS 10 MG/4 ML VIAL 4ML, a pharmaceutical product. The contract has a ceiling value of $19,331.43 and a period of performance ending on April 25, 2024. This award is made under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a potential value of up to $999,999,999.00 and runs through December 31, 2025. The IDC serves as the primary vehicle for AmerisourceBergen to deliver a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.3k | 4/24/24 |